Back
Ligand Pharmaceuticals Vs. Pieris Pharmaceuticals Industry Stock Comparison
Buy
57
LGND
Ligand Pharmaceuticals
Last Price:
119.43
Seasonality Move:
15.47%
Sell
43
PIRS
Pieris Pharmaceuticals
Last Price:
16.64
Seasonality Move:
14.9%
Buy
57
Ligand Pharmaceuticals (LGND)
is a Buy
Is Ligand Pharmaceuticals a Buy, Sell or Hold?
- The current Ligand Pharmaceuticals [LGND] share price is $116.55. The Score for LGND is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- LGND is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Pieris Pharmaceuticals (PIRS)
is a Sell
Is Pieris Pharmaceuticals a Buy, Sell or Hold?
- The current Pieris Pharmaceuticals [PIRS] share price is $15.93. The Score for PIRS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- PIRS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LGND Stock Price Chart
What is Ligand Pharmaceuticals's stock price today?
-
The Ligand Pharmaceuticals share price today is $116.55
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LGND is experiencing slight buying pressure.
PIRS Stock Price Chart
What is Pieris Pharmaceuticals's stock price today?
-
The Pieris Pharmaceuticals share price today is $15.93
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PIRS is experiencing buying pressure, which is a positive indicator for future bullish movement.
LGND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.89 | Buy |
Relative Strength Index (14 RSI): | 54.92 | Buy |
Chaikin Money Flow: | 40059 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (107.54 - 119.52) | Buy |
Bollinger Bands (100): | (96.78 - 111.88) | Buy |
PIRS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.24 | Sell |
Relative Strength Index (14 RSI): | 43.29 | Sell |
Chaikin Money Flow: | 8327 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.01 - 17.05) | Sell |
Bollinger Bands (100): | (12.17 - 18.69) | Buy |
LGND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 115.19 | Buy |
20-day SMA: | 115.03 | Buy |
50-day SMA: | 107.92 | Buy |
200-day SMA: | 91 | Buy |
8-day EMA: | 114.75 | Buy |
20-day EMA: | 113.91 | Buy |
50-day EMA: | 109.5 | Buy |
200-day EMA: | 94.41 | Buy |
PIRS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.88 | Buy |
20-day SMA: | 16.45 | Sell |
50-day SMA: | 16.52 | Sell |
200-day SMA: | 13.81 | Buy |
8-day EMA: | 15.95 | Sell |
20-day EMA: | 16.25 | Sell |
50-day EMA: | 16.27 | Sell |
200-day EMA: | 17.42 | Sell |
Ligand Pharmaceuticals Earnings Growth & LGND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and an increase next year of $0.38 per share.
Pieris Pharmaceuticals Earnings Growth & PIRS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and a decrease next year of $0.09 per share.
Ligand Pharmaceuticals Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Pieris Pharmaceuticals Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |